Both immunogenetic factors and HCV genotype can influence the outcome of chronic HCV infection

Statin therapy: improving survival in patients with hepatocellular carcinoma and portal hypertension is possible?

Acta gastro-enterologica Belgica·2024

Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)-A European Society of Organ Transplantation (ESOT) Consensus Statement.

Transplant international : official journal of the European Society for Organ Transplantation·2023

The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities.

Journal of viral hepatitis·2018

Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis.

Journal of viral hepatitis·2017

Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015